Navigation Links
Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus

re and infection."

While previous studies had linked end-stage dementia due to HIV to the presence of infected and activated immune cells, the nature of neurological changes in earlier stages of the disease, the so-called "chronic phase," were unknown-until now.

Using simian immunodeficiency virus-infected models in the chronic phase, the research team found both virus and infiltrating lymphocytes (CD8+ T cells) in the brain. Molecular analysis revealed that the expression of several immune response genes was increased, including CCL5, which has multiple effects on neurons as well as immune cells. CCL5 was significantly upregulated throughout the course of infection, and was present in the infiltrating lymphocytes.

In addition to Fox, authors of the April 26, 2006 Journal of Neuroscience (Volume 26, Number 17) paper, titled "Host Response and Dysfunction in the CNS During Chronic SIV Infection," are: Eleanor Roberts, Salvador Huitron-Resendiz, Michael Taffe, Cecilia Marcondes, Claudia Flynn, Caroline Lanigan, Jennifer Hammond, Steven Head, and Steven Henriksen.


'"/>

Source:Public Health Agency of Canada


Page: 1 2

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental shingles vaccine proves effective in nationwide study
3. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
4. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
5. Experimental RNA-based drug kills prostate cancer cells effectively and safely
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental vaccine protects mice against deadly 1918 flu virus
8. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Research advances quest for HIV-1 vaccine
11. A much-needed shot in the arm for HIV vaccine development

Post Your Comments:
(Date:11/6/2009)...TROIT, Nov. 6 Auburn Hills, MI-bas... will be installing its locker system and patent-p...at the U.S. Department of Health and Human Service...thesda, MD. The locker system will support the NI...otecting our nation,s medical research agency. Th...
(Date:11/4/2009)...ELPHIA Although scientists are reluctant to offic...hod, evidence continues to grow about its protecti...shed in Cancer Prevention Research , a journal of...ch suggests some reduction in oral cancer. , Va...icine in the Department of Thoracic/Head and Neck ...
(Date:11/4/2009)...ngapore laboratory that deciphered the DNA codes, ...elephant shark, has joined The Genome 10K Project,...pository of DNA sequences on 10,000 species of ani... that currently can not be achieved. , Participa...er published in the Nov. 5, 2009 issue of the Jou...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Adam 26 Eves Great American Sex Survey Asks How Was YOUR First Time 3F 57838 1Adam 26 Eves Great American Sex Survey Asks How Was YOUR First Time 3F 57838 2Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 1Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 2Perrigo Company To Host Investor Day 57833 1
...xpected to exacerbate drought events throughout th...tion and failure of drought-sensitive crops. In a... in severity and length, making it difficult for p...dern varieties of potatoes are considered to be dr...on in the cold, dry Andean Altiplano gave rise to ...
...toes can be up to 1000 times larger than their wil..., domesticated food plants have larger fruits, hea...he characteristics that early hunter-gatherers cho...omatoes have been bred for shape, texture, flavor,...been difficult to study these traits in tomatoes, ...
...vailable in French and Spanish . , Montreal, ...re joining forces to protect and conserve the Mona...America,s shared environment. , Although the mona...r of extinction, its unique multigenerational migr...ngered biological phenomenon due to threats to the...
Other Biology News:Drought tolerance in potatoes 2Drought tolerance in potatoes 3Evolution of fruit size in tomato 2Evolution of fruit size in tomato 3Continental plan to protect the monarch's migratory journey 2
(Date:11/5/2009)... November 5, 2009 Senomy...ng proprietary taste receptor-based technologies t...beverage, and ingredient supply industries, today ... results for the third quarter ended September 30,...uarter of 2009, compared to $4.0 million for the t...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria announ...matics earned the Certified Professional in Learni...he American Society for Training and Development (...as more than fifteen years of medical communicatio...onsible for the development of the company,s onlin...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be st... feature film "A Call to Arms:2009 Edition&qu...Fatal Immunity: The Human Anthrax Vaccine Story&qu...nt danger of top secret government science turned ...ountability to its victims. It is available for w...
(Date:11/4/2009)...lif., Nov. 4 Onyx Pharma...hat it will present at the Credit Suisse 18th Annu..., at 9:30 a.m. Mountain Time (8:30 a.m. Pacific Ti... of the presentation on our website at: http://w..., It is recommended that listeners log on 15 minu...
Breaking Biology Technology:SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
...nc. (Nasdaq: DCTH ), a medical technology compa...rfusion ("PHP") System for the treatment of cancer...ty percent (46 of 92) of patients have been enroll...atic cutaneous and ocular melanoma to the liver. ...ial continue to evaluate and enroll patients and t...
.../ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ON...eeded the primary statistical endpoint in its mult...travenous administration of REOLYSIN(R) in patient...the lung. , "The proportion of patients on study...responses is highly encouraging," said Dr. Frank G...
... announced today,that it has agreed with Pfizer to...edients (API) site in Ireland. This site manufactu...l ingredient. , The site has had a number of..., then Hickson & Welch, Warner Lambert, Pfizer...s invested several hundred million dollars in,plan...
Other Biology Technology:Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 2Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 3Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 2Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 3Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 4Hovione Buys Pfizer's Loughbeg API Facility 2Hovione Buys Pfizer's Loughbeg API Facility 3
Rabbit Anti-KIAA1276 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Cytokeratin 5 / 14 Monoclonal Antibody, Unconjugated, Clone LH8 from Abcam
Rabbit Anti-IL-23 P19 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human C1QC Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: